申请人:Axikin Pharmaceuticals, Inc.
公开号:US20130065889A1
公开(公告)日:2013-03-14
Provided herein are 2,5-disubstituted arylsulfonamide CCR3 antagonists, e.g., compounds of Formula I, and pharmaceutical compositions thereof: Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.